Klein Lawrence Otto

CIK 00017625835 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001762583

Recent Transactions

50 trades

Award
Oruka Therapeutics, Inc.$ORKA
Common Stock
2026-01-23+76,700→ 929,038 total
Award
Oruka Therapeutics, Inc.$ORKA
Employee Stock Option (right to buy)
2026-01-23+306,700→ 306,700 total
Award
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2025-04-29+23,017→ 23,017 total
Award
Oruka Therapeutics, Inc.$ORKA
Employee Stock Option (right to buy)
2025-01-22+230,000→ 230,000 total
Award
Jasper Therapeutics, Inc.$JSPR
Stock Option (right to buy)
2023-06-07+47,000→ 47,000 total
Award
Jasper Therapeutics, Inc.$JSPR
Voting Common Stock
2022-10-12+24,500→ 24,500 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2022-08-16+12,500→ 12,500 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2022-07-05+7,222→ 7,222 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2022-06-03+19,596→ 19,596 total
Award
Jasper Therapeutics, Inc.$JSPR
Stock Option (right to buy)
2022-03-21+78,045→ 78,045 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2022-03-14$61.08/sh−1,229→ 26,797 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2022-03-11+3,000→ 28,026 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2022-03-11−3,000→ 9,000 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2022-03-11$62.56/sh−1,883→ 25,026 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2022-03-10+4,584→ 26,909 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2022-03-10−4,584→ 4,583 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2022-02-18+46,200→ 46,200 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2022-02-18+20,400→ 20,400 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2021-12-06$69.17/sh−11,185→ 22,325 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2021-12-03+26,667→ 33,510 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2021-12-03+26,667→ 13,333 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2021-10-15+13,800→ 13,800 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2021-09-13$117.86/sh−4,207→ 6,843 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2021-09-10−10,000→ 0 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2021-09-10+10,000→ 11,050 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2021-05-26+19,596→ 19,596 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2021-03-23−22,000→ 38,000 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-03-23$128.20/sh−88,000→ 13,050 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2021-03-23−10,000→ 10,000 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2021-03-23$51.49/sh+22,000→ 47,050 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2021-03-23$17.66/sh+12,000→ 101,050 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-03-23$126.97/sh−12,000→ 1,050 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2021-03-23−12,000→ 3,000 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2021-03-23−12,000→ 43,000 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2021-03-23$44.67/sh+12,000→ 25,050 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2021-03-23$29.87/sh+10,000→ 57,050 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2021-03-23$14.43/sh+12,000→ 89,050 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2021-03-23−12,000→ 2,666 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2021-03-23$40.87/sh+20,000→ 77,050 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2021-03-23−20,000→ 25,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2021-03-11+33,334→ 33,334 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2021-03-11+12,000→ 12,000 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2021-03-10+4,583→ 15,191 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2021-03-10$124.15/sh−2,141→ 13,050 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-01-15$216.39/sh−1,500→ 30,700 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-01-15$218.54/sh−701→ 20,002 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-01-15$214.46/sh−1,400→ 20,600 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-01-15$217.45/sh−200→ 20,000 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-01-15$213.64/sh−2,800→ 32,900 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-01-15$219.99/sh−2→ 20,000 total

Companies

Recent Filings

Address

C/O ORUKA THERAPEUTICS, INC. 855 OAK GROVE AVE., SUITE 100

MENLO PARK, CA, 94025

View on SEC.gov